Tetsuya Yamada, Managing Director, OMRON Healthcare, India
Being built with an investment of Rs 128 crore, this state-of-the-art facility will mark the company’s debut in the healthcare manufacturing space in India and will further strengthen its presence in the home healthcare device industry in the country as well as its global network of production facilities with locations in Japan, China, Vietnam, Italy and Brazil. In conversation with BioSpectrum Asia, Tetsuya Yamada, Managing Director, OMRON Healthcare India talks about the company’s growth plans in Asia. Edited excerpts:
What are the key global highlights at OMRON Healthcare for FY 2023-24?
OMRON Healthcare, worldwide, strives to work towards empowering people to live life to the fullest by providing them with innovative health monitoring and wellness devices. This endeavour is captured in its vision ‘Going For Zero’ which aims for propagating preventive care to achieve a society where there are Zero cerebrovascular and cardiovascular events, Zero aggravation of respiratory diseases and Zero restrictions of daily activities due to chronic pain. For FY 2023-24, the company’s key initiatives will focus on enhancing the reach and availability of digital BP monitors for hypertension management, coming up with more innovative devices for cardiovascular disease management and also accelerate further expansion in the Remote Patient Monitoring (RPM) services domain.
Are you planning to launch new products this year? Are there any new partnerships or investments in the pipeline?
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Sep 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Sep 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
"We are dedicated to helping people of all ages see brilliantly"
The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.
Building the Future of Medicine
PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical
Emerging Leader in Cell & Gene Therapy
STARTUP OF THE YEAR 2024 - ImmunoACT
Improving Access for Respiratory Healthcare
STARTUP OF THE YEAR 2024 - Aevice Health
Making an Impact with a 'CliKX'
Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ
Eyeing 20-20 Vision of Excellence
Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research
Refining the Use of Radiation
Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals
Honouring Innovators in Asia's Thriving Life Sciences Sector
Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.
How To Control Indian Diabetes Growth
World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.
